STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 103,393	$ 92,889
General and administrative	28,884	30,651
Total operating expenses	132,277	123,540
Loss from operations	(132,277)	(123,540)
Other income, net	10,445	8,102
Net loss	$ (121,832)	$ (115,438)
Per share information:
Net loss per share of common stock, basic	$ (2.02)	$ (2.44)
Net loss per share of common stock, diluted	$ (2.02)	$ (2.44)
Weighted average common shares outstanding, basic	60,357,052	47,371,589
Weighted average common shares outstanding diluted	60,357,052	47,371,589
Comprehensive loss
Net loss	$ (121,832)	$ (115,438)
Unrealized gain (loss) on marketable securities, net of tax	1,915	(981)
Comprehensive loss	$ (119,917)	$ (116,419)